JAGX
Jaguar Health, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.71
−1.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.14x
- Price / sales
- 0.03x
- Price / cash flow
- -0.14x
Enterprise value
- Enterprise value
- $9.3M
- EV / sales
- 0.33x
- EV / EBITDA
- -0.23x
- EV / EBIT
- -0.37x
- Market cap
- $933.7K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026